MilletaVita is a first-of-its-kind millet-yogurt functional beverage format that combines Indian millet nutrition, probiotic benefits, and shelf-stable convenience in one ready-to-use solution. Unlike regular flavoured yogurt, millet drinks, or conventional probiotic beverages, MilletaVita is designed to be portable, refrigeration-free, gut-friendly, and suitable for modern on-the-go lifestyles. By addressing short shelf life, cold-chain dependence, and limited probiotic innovation, the product creates a new category with no direct commercial equivalent in the current market. The business will follow a multi-channel revenue model built around repeated consumption of single-serve probiotic millet-yogurt sachets, supported with packaged water for convenient preparation. The primary revenue stream will come from D2C sales through the company website, e-commerce platforms, and direct campus-focused sales targeting university and college students, faculty, researchers, and staff who need healthy, convenient nutrition during busy schedules. The second revenue stream will come from retail distribution through health stores, pharmacies, supermarkets, and wellness outlets, beginning in Lucknow and gradually expanding into Tier 1 and Tier 2 cities. The third stream will focus on subscription plans, offering monthly wellness packs for working professionals, fitness users, frequent travellers, and health-conscious families. The fourth stream will include B2B institutional sales through gyms, airlines, corporate wellness programmes, hospitals, travel outlets, and wellness partners. In later stages, revenue can further expand through regional distributors, export-ready packaging, and co-branded wellness partnerships. MilletaVita will begin its commercial journey from Lucknow as the base city. Grant support will be used to establish essential R&D, testing, and pilot-scale production infrastructure required for microbial fermentation, probiotic validation, shelf-life studies, product standardization, packaging trials, and regulatory compliance. The grant will help build core capabilities such as controlled fermentation systems, culture handling, quality-control testing, freeze-drying, packaging validation, and pilot-scale product development. Once the product is validated, sales will expand from Lucknow to nearby markets and major Tier 1 cities such as Delhi, Mumbai, Bengaluru, and Hyderabad, followed by Tier 2 cities such as Jaipur, Pune, Coimbatore, and other wellness-focused urban markets. As demand increases, scale-up will be managed through biotechnology-driven systems, including standardized probiotic strain banks, optimized starter cultures, controlled bioreactor fermentation, batch-wise quality checks, expanded lyophilization capacity, and approved co-manufacturing partners. This will help ensure consistent probiotic potency, product safety, shelf stability, and faster supply to the market without compromising quality. The core revenue model will remain sachet-based, with multiple scalable channels including D2C sales, marketplaces, subscription packs, modern retail, pharmacies, health stores, gyms, corporate wellness programmes, airlines, and institutional B2B partnerships. At a blended ASP of ₹48 and COGS of ₹18, MilletaVita can earn a contribution of ₹30 per sachet, creating strong unit economics and repeat-purchase potential. The subscription model will support predictable recurring revenue, while retail and B2B channels will drive faster volume growth across Lucknow, Tier 1 cities, Tier 2 markets, and eventually pan-India distribution. Overall, this multi-channel model allows MilletaVita to scale efficiently while maintaining affordability, convenience, product quality, and profitability.
Show MoreYear of Establishment2024